Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Rohan Kamlesh Tewani
Observed names:
R.K. Tewani,
Rohan Tewani
Institution:
Basavatarakam Indo American Cancer Hospital and Research Institute
Observed institution:
Basavatarakam Indo American Cancer Hospital and Research Institute
ORCID:
0009-0004-1024-185X
Observed ORCID:
0009-0004-1024-185X
OpenAlex ID:
A5055257169
The clinical utility and safety of short‐course immune checkpoint inhibitors in multiple tumours—A real‐world multicentric study from India
2021
·
George Abraham
, Vanita Noronha
, et al.
·
International Journal of Cancer
·
9
PDF
Factors associated with pathologic complete response following neoadjuvant chemoradiation and esophagectomy for carcinoma of esophagus and gastroesophageal junction
2022
·
Syed Nusrath
, Subramanyeshwar R. Thammineedi
, et al.
·
Journal of Surgical Oncology
·
7
PDF
Optimizing quality of life: integrating palliative care for patients with hand-foot syndrome in oncology practice
2024
·
Divya Sai Vanumu
, Praveen Kumar Kodisharapu
, et al.
·
BMJ Supportive & Palliative Care
·
3
Real‐World Safety and Efficacy of Biosimilar Trastuzumab Emtansine (T‐DM1) in HER2‐Positive Breast Cancer: A Prospective Single‐Institution Study From India
2026
·
Divya Gandrala
, Senthil J. Rajappa
, et al.
·
International Journal of Breast Cancer
·
1
Impact of Early Cyclosporine on Cytokine Release Syndrome and Outcomes in Pediatric Haploidentical Hematopoietic Stem Cell Transplantation
2025
·
Veerendra C. Patil
, Siddhartha Reddy Dodda
, et al.
·
Pediatric Transplantation
·
1
PDF
Diffuse Large B-Cell Lymphoma: From Molecular Stratification to Precision Immunotherapy
2026
·
Akbar Pasha
, Aayushi Velingkar
, et al.
·
Cells
Neoadjuvant intravenous biosimilar pertuzumab and trastuzumab versus subcutaneous pertuzumab/trastuzumab/hyaluronidase (Phesgo) in HER2-positive breast cancer: A real-world comparative study.
2026
·
Divya Gandrala
, Krishna Mohan V T. Mallavarapu
, et al.
·
Journal of Clinical Oncology
250eP Rectal cancer care in LMIC: Insights, challenges, and outcomes
2025
·
H. Abbaraju
, P. Nikhil
, et al.
·
Annals of Oncology
Abstract P3-05-04: Understanding access to HER2-targeted therapy among breast cancer patients treated in a resource-constrained setting: Cross-sectional observational cohort analyses
2025
·
Mounika M Guru Reddy
, M V T Krishna Mohan
, et al.
·
Clinical Cancer Research
Testing Patterns and Prevalence of gBRCA Mutations among Women with Breast Cancer: A Cross-Sectional Observational Study
2025
·
S. Sana Ali
, Rakesh Pinninti
, et al.
·
Indian Journal of Medical and Paediatric Oncology
PDF
Integrated analysis of non-HLA and HLA factors predicting GVHD, Relapse, and survival in pediatric haploidentical transplantation
2025
·
Siddhartha Reddy Dodda
, Anjana Alekhya Somayajula
, et al.
·
Pediatric Hematology Oncology Journal
Treatment Outcomes in Advanced Biliary Tract Cancers: Single Institution Retrospective Analysis
2024
·
Nikhil Pathi
, Senthil J. Rajappa
, et al.
·
Indian Journal of Medical and Paediatric Oncology
Safety and efficacy of biosimilar TDM-1: A real world retrospective study.
2024
·
Divya Gandrala
, Krishna Mohan V T Mallavarapu
, et al.
·
Journal of Clinical Oncology
Being a Resident in the COVID Era: It Changed Everything
2020
·
Rohan Tewani
·
Indian Journal of Medical and Paediatric Oncology
PDF
Scrub Typhus Meningitis from Urban Delhi - An Atypical Presentation
2015
·
Darbari Lal
, Rohan Tewani
, et al.
·
JOURNAL OF COMMUNICABLE DISEASES
Show more works
View as search
Works count:
15
Citation count:
21
H-index:
3
I10-index:
Year
Topic
Type